HIF hydroxylase pathways in cardiovascular physiology and medicine.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26089364.
- Also identified by DOI 10.1161/CIRCRESAHA.117.305109 and PMC identifier 4501273.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hypoxia inducible factors (HIFs) are α/β heterodimeric transcription factors that direct multiple cellular and systemic responses in response to changes in oxygen availability. The oxygen sensitive signal is generated by a series of iron and 2-oxoglutarate-dependent dioxygenases that catalyze post-translational hydroxylation of specific prolyl and asparaginyl residues in HIFα subunits and thereby promote their destruction and inactivation in the presence of oxygen. In hypoxia, these processes are suppressed allowing HIF to activate a massive transcriptional cascade. Elucidation of these pathways has opened several new fields of cardiovascular research. Here, we review the role of HIF hydroxylase pathways in cardiac development and in cardiovascular control. We also consider the current status, opportunities, and challenges of therapeutic modulation of HIF hydroxylases in the therapy of cardiovascular disease.
Medical subject headings
- Cardiovascular Diseases
- Cardiovascular System
- Hypoxia-Inducible Factor 1, alpha Subunit
- Hypoxia-Inducible Factor-Proline Dioxygenases